Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Bailey

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The Journal of Biological Chemistry|March 30, 2001
A dynamic role for HDAC7 in MEF2-mediated muscle differentiationU Dressel, P J Bailey, S C Wang, et al.
Biochemical and Biophysical Research Communications|February 15, 1989
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoJ I Germershausen, V M Hunt, R G Bostedor, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and antiinflammatory/analgesic activities of 11H-dibenzo[b, e,][1,4]dioxepinacetic acidsW K Hagmann, C P Dorn, R A Frankshun, et al.
The British Journal of Surgery|January 18, 2018
Defining the molecular pathology of pancreatic body and tail adenocarcinomaS B Dreyer, N B Jamieson, R Upstill-Goddard, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamideP J Bailey, A L Dallob, D L Allison, et al.
Journal of Medicinal Chemistry|May 1, 1982
Lysosomotropic agents. 4. Carbobenzoxyglycylphenylalanyl, a new protease-sensitive masking group for introduction into cellsR A Firestone, J M Pisano, P J Bailey, et al.
Oncogenesis|November 17, 2018
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapyV L Veenstra, H Damhofer, C Waasdorp, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The Journal of Biological Chemistry|March 30, 2001
A dynamic role for HDAC7 in MEF2-mediated muscle differentiationU Dressel, P J Bailey, S C Wang, et al.
Biochemical and Biophysical Research Communications|February 15, 1989
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivoJ I Germershausen, V M Hunt, R G Bostedor, et al.
Journal of Medicinal Chemistry|August 1, 1986
Synthesis and antiinflammatory/analgesic activities of 11H-dibenzo[b, e,][1,4]dioxepinacetic acidsW K Hagmann, C P Dorn, R A Frankshun, et al.
The British Journal of Surgery|January 18, 2018
Defining the molecular pathology of pancreatic body and tail adenocarcinomaS B Dreyer, N B Jamieson, R Upstill-Goddard, et al.
Arzneimittel-Forschung|March 1, 1988
Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamideP J Bailey, A L Dallob, D L Allison, et al.
Journal of Medicinal Chemistry|May 1, 1982
Lysosomotropic agents. 4. Carbobenzoxyglycylphenylalanyl, a new protease-sensitive masking group for introduction into cellsR A Firestone, J M Pisano, P J Bailey, et al.
Oncogenesis|November 17, 2018
ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapyV L Veenstra, H Damhofer, C Waasdorp, et al.
Pageof 6